Danny Farin CEOBSc, MBA. Entrepreneur in the biomed industry and the former CEO and Co-Founder of Eon Surgical, a RAD BioMed portfolio company, which was successfully acquired by Teleflex in 2013.
Dr. Yaacov AmsalemDr. Yaacov Amsalem, MD, Medical Director, Head of interventional neuro-radiology, Rambam Medical Center.
Gilad CibulskiGilad Cibulski, BSc. Founder & Project Manager, Partner at Tailormed and a former project manager at FD Cardio and at MindGuard.
Avi RapaportAvi Rapaport, BSc, Founder, Partner at Tailormed and former VP R&D at FD Cardio and Director of Engineering at MindGuard.
For more Information please visit:
Scientific Advisory Board
Prof. Randall T. Higashida
Prof. Randall T. Higashida, MD, Chief of the Division of Interventional Neurovascular Radiology at UCSF Medical Center.
Prof. Reza JahanProf. Reza Jahan, MD, Assistant Professor at the Interventional Neuroradiology & Neurosurgery Dept of Radiological Sciences UCLA Medical Center.
Prof. David TanneProf. David Tanne, MD, Vascular Neurologist, Fellowship: Henry Ford Medical Center, Michigan. Associate Professor of Neurology, Tel Aviv Univ. Stroke Center, Department of Neurology, Sheba MC, Israel
Technological Feasibility Study
Perflow Medical is developing a user-adjustable device to restore blood flow to the brain and remove the occluding clot quickly and safely in patients experiencing gacute ischemic stroke. The device is a self-expanding, tretrivable nitinol tubular braided dense mesh that can be deployed easily with a standard microcatheter.
Stroke is the 4th most common cause of death in industrial nations, and the number 1 cause of permanent disability.
1 in 5 men and 1 in 6 women will experience a stroke. Annually, 795,000 people in the US will experience a stroke.
97% of stroes are ischemic, meaning they are associated with a blod clot in a cerebral vessel.
Direct and indirect costs of stroke in the US are over $73 billion annually.